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For personalAbstract Background: According to the new definition of septic shock, vasopressor therapy
and hyperlactatemia are essential for diagnosis. However, there is controversy regarding the
cutoff value for lactate, and prognostic factors in patients with septic shock and hypolactate-
mia. This study evaluated the prognostic significance of the cutoff value for lactate level in
septic shock patients.
Methods: The retrospective observational cohort study enrolled 1043 patients aged 18 years
who meet the revised definition of septic shock. Clinical outcomes of patients with hyperlac-
tatemia were compared with hypolactatemia.
Results: Of the 1022 eligible patients, 369 had an arterial lactate level 2 mmol/L. More pa-
tients in the high lactate group had poor prognosis than in the low lactate group. A high
Sequential Organ Failure Assessment score (SOFA) score group was significant (p < 0.001) in
predicting lactate levels. On the subgroup analysis of risk factors affecting mortality in the
low lactate group, high Acute Physiology And Chronic Health Evaluation Ⅱ (APACHEⅡ) score
(p Z 0.003), high C-reactive protein (p Z 0.034), and chronic heart failure (p Z 0.001) were
independently associated with 28-day mortality.of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722,
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shock. However, despite low arterial lactate, patients with a high APACHEⅡ score, high C-reac-
tive protein levels, and chronic heart failure had a poorer prognosis.
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Sepsis was defined as suspected infection that satisfied
diagnostic criteria of the systemic inflammatory response
syndrome (SIRS) for the last two decades.1,2 However,
sepsis is now understood as a comprehensive host response
to infecting pathogens.3 Therefore, the definitions of sepsis
and septic shock need revision.
To compensate for the fact that inflammation has
various courses, while SIRS criteria does not adequately
reflect the infection-induced inflammation, new definitions
of sepsis and septic shock were announced through Singer
et al. in February 2016.4 Sepsis is defined as life-
threatening organ dysfunction caused by a “dysregulated
host response” to infection. A Sepsis-related Organ Failure
Assessment (SOFA) score 2 was selected for organ
dysfunction.4,5 Septic shock is a subset of sepsis with un-
derlying “circulatory and cellular metabolic abnormalities”
that increase mortality. As index for diagnosis septic shock,
‘need for vasopressor therapy’ and ‘hyperlactatemia’
(lactate >2 mmol/L despite adequate fluid resuscitation)
were selected by the Delphi process.6
Lactate has been used as a prognostic marker of sepsis
and septic shock. Upon contracting sepsis, patients expe-
rience hyperlactatemia caused by lactate overproduction
as a consequence of tissue hypoperfusion and sepsis itself,
as well as diminished lactate clearance due to hepatic
dysfunction and renal dysfunction.7 In Shankar-Hari et al.,
the adjusted odds ratio (OR) for hospital mortality
increased linearly with increasing lactate levels. Lactate
level >2 mmol/L was chosen as the cutoff value for diag-
nosis of septic shock.6 However, there are many institutions
that do not initially measure lactate level.8 There are pa-
tients who with signs of septic shock with hypolactatemia
show poor outcomes.9e11 Therefore, the appropriate cutoff
value for lactate level remains controversial.
Our objective was to evaluate the prognostic signifi-
cance of the cutoff value for lactate through comparison of
clinical presentation and outcome between septic shock
patients with high and low lactate levels.Material and methods
Patients and study design
We included critically ill patients who visited the emer-
gency department (ED) of Severance Hospital at Yonsei
University College of Medicine, a 2000-bed, tertiary referral
hospital in South Korea from November 2007 to March 2016.
This retrospective cohort study targeted patients enrolledDH, et al., Risk factors for morta
ion (2017), http://dx.doi.org/10.
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Therapy, a 6-h bundle established for managing patients
with septic shock as quickly and effectively as possible.
Protocol of CP was revised to reflect the guidelines of
Surviving Sepsis Campaign. The protocol was approved by
the institutional review board of Yonsei University Health
System Clinical Trial Center. All patients visiting the ED
were screened. Patients who satisfied two or more SIRS
criteria and showed signs of infection were evaluated for
eligibility in CP. Initiation of CP was triggered by one of the
following two conditions: a) initial systolic blood pressure
<90 mmHg despite adequate fluid resuscitation, or b) initial
arterial lactate level 4 mmol/L. These standards followed
the Surviving Sepsis Campaign guideline designed by Del-
linger et al.12
Exclusion criteria included: a) age under 18 years, b) any
contraindication to central venous catheterization, c)
pregnancy, d) acute cerebrovascular accident, e) acute
coronary syndrome, f) active gastrointestinal bleeding, g)
trauma, h) drug overdose, i) the need for immediate sur-
gery, j) lack of informed consent, k) transfer to another
institution, and l) do-not-resuscitation order. A total of
1043 patients were enrolled in this study.
The resuscitation team consisted of specialists in
emergency medicine, division of infectious disease, pul-
monology, and anesthesiology. Vital signs, such as blood
pressure, heart rate, respiration rate, and body tempera-
ture, were checked and recorded when patients visited the
ED. In septic patients, fluid resuscitation was initiated via
insertion of a central venous catheter into the internal ju-
gular vein or subclavian vein. Per protocol, crystalloids
were used as resuscitative fluids and norepinephrine was
used for a vasopressor. Central venous pressure (CVP),
mean arterial pressure (MAP), and central venous oxygen
saturation (ScvO2) were checked every hour for 6 h. The
success or failure of CP was analyzed using this data.
Data collection
Baseline characteristics such as age, sex, height, weight,
and preexisting comorbidities, such as, hypertension, dia-
betes mellitus, chronic kidney disease, chronic heart fail-
ure (CHF), coronary disease, dementia, lung disease,
autoimmune or connective tissue disease, liver disease,
malignancy, human immunodeficiency virus infection, and
history of organ transplantation were extracted. Treatment
modalities and interventions in the process of treatment
such as transfusion, vasopressor therapy, ventilator care,
and hemodialysis were also noted.
Laboratory tests were performed according to protocol.
Initially, complete blood count, C-reactive protein (CRP),lity in patients with low lactate level and septic shock, Journal of
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filtration rate (eGFR), total bilirubin, albumin, lactate,
prothrombin time (International Normalized Ratio), D-
dimer, antithrombin Ⅲ, fibrinogen, fibrin degradation
product, arterial blood gas analysis, and bacterial cultures
were obtained from blood, sputum, and urine samples.
Severity of disease and degree of organ failure were eval-
uated using the Acute Physiology and Chronic Health Eval-
uation (APACHEⅡ) and SOFA scores. Follow-ups continued
until patients’ death during hospitalization period or their
first visit to outpatient clinic after patients being dis-
charged. Occurrence of organ failure in this study was
determined by reviewing the patients’ medical records as
well as results of laboratory tests and special examinations,
such as echocardiography, within 28 days after hospitali-
zation. Mortalities were classified as 7-day mortality, 28-
day mortality, and mortality after 28 days.
Definition and resuscitation goals
The high lactate group was defined as the group of patients
with arterial lactate >2 mmol/L and the low lactate group
was defined as a patient group with arterial lactate
2 mmol/L or less. Thrombocytopenia was defined as the
platelet count below 150  103 cells/mm3. Renal failure
was defined as serum Cr equal to or above 2.0 mg/dL, or
urine output below 500 ml/day.13 Acute respiratory distress
syndrome was defined as the ratio of the partial pressure of
arterial oxygen to the fraction of inspired oxygen below
300 mmHg and bilateral opacities not fully explained by
pleural effusion, lung collapse, and nodules on chest im-
aging.14 Hepatic failure was defined as serum total bilirubin
equal to or above 2.0 mg/dL.15 Newly developed heart
failure (HF) was defined as left ventricular ejection fraction
below 50% on echocardiography.16 Disseminated intravas-
cular coagulation (DIC) was diagnosed based on a score 5
according to guidelines of the International Society on
Thrombosis and Hemostasis when thrombocytopenia,
elevated D-dimer level, prolonged prothrombin time, and
decreased fibrinogen level were combined.17
Patients were treated according to a CP protocol for at
least 6 h, after which monitoring of ScvO2 was discontinued
if the initial resuscitation goal was achieved (resuscitation
criteria: CVP of 11e15 cmH2O, MAP of 65e90 mmHg, and
ScvO2 greater than 70% in the initial 6 h).
Statistical analysis
Continuous variables are expressed as mean  standard
deviation or median (interquartile range). Categorical var-
iables were compared using c2 analysis, and continuous
variables with normal distributions were compared using
the Student’s t test. The ManneWhitney U test was used to
compare continuous variables with a skewed distribution.
Variables with a p value < 0.05 on bivariate analysis were
included in the logistic regression model for multivariate
analysis of 28-day mortality in the low lactate group.
Adjusted ORs were calculated using a logistic regression
model. KaplaneMeier curves were used to compare 7-day
mortality and 28-day mortality between high and low
lactate groups. Single linear univariate correlationPlease cite this article in press as: Oh DH, et al., Risk factors for morta
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regression analyses were performed to evaluate the rela-
tionship between SOFA score and serum lactate level. The
optimal cutoff value for SOFA score was estimated to
maximize the sum of the sensitivity and specificity derived
from receiving operating characteristic curves and area
under the curve (Youden index) using SOFA scores for 1022
patients. The estimated cutoff value for SOFA score in this
study was 7.5 (AUC 0.713, p < 0.001). All statistical analyses
were performed using the Statistical Package for the Social
Sciences 18.0 software (SPSS Inc., Chicago, IL, USA).
p values less than 0.05 were considered statistically
significant.Results
During the study period, we enrolled 1043 patients. We
excluded 21 patients due to missing data. The high lactate
group included 653 (63.9%) patients (Fig. 1). Mean age of
participants was 65.7  14.4 years, and total mortality rate
was 16.0% (164/1022). Proportion of patients who received
vasopressor was 95.8% (979/1022).
Table 1 shows the baseline characteristics and labora-
tory data of patients with high and low lactate levels. The
mean age of patients in the high lactate group was higher
than the low lactate group (66.9  13.4 vs. 63.6  15.8
years, pZ 0.010). Male sex had a significant impact on the
differences between the two groups (56.0 vs. 42.5%,
p < 0.001). In addition, the incidence of diabetes mellitus
(36.8 vs. 27.1%, pZ 0.002) and malignancy (36.4 vs. 30.1%,
p Z 0.040) were statistically different between the two
groups. Initial ScvO2 (80.2 [72.0e88.3] vs. 83.8
[76.0e94.5]%, p < 0.001) was higher in the low lactate
group than in the high lactate group.
Platelet count (159.0 [87.5e247.5] vs. 214.0
[156.3e290.0]  103 cells/mm3, p < 0.001), eGFR (39.0
[22.2e60.7] vs. 53.0 [32.2e75.0] mL,min-1,1.73 m-2,
p < 0.001), and serum albumin level (3.0  0.7 vs.
3.3  0.7 g/dL, p < 0.001) were lower in the high lactate
group than in the low lactate group.
Regarding the severity of illness at the time of admission
to the ED and pre-CP, the SOFA score (9.08  3.03 vs.
6.97  2.32, p < 0.001) and APACHEⅡ score (18.56  7.15
vs. 14.02  5.97, p < 0.001) were higher in the high lactate
group than in the low lactate group (Table 1).
Table 2 shows the results of resuscitation, incidence of
organ failure, and mortality in the two groups. The MAP, 6 h
after initiation of CP was higher in the low lactate group
than in the high lactate group (81.3  14.1 vs.
84.4  14.6 mmHg, p Z 0.028). Six-hour CVP and ScvO2
were not significantly different between the two groups.
The high lactate group had a significantly high percentage
of CP goal achievement (50.8 vs. 43.9%, p Z 0.037). Organ
failure was significantly more frequent in the high lactate
group than in the low lactate group. Seven-day mortality
(10.3 vs. 1.6%, p < 0.001) and 28-day mortality (15.6 vs.
4.9%, p < 0.001) were significantly higher for the high
lactate group than the low lactate group (Fig. 2a).
On multivariate analysis, SOFA score of 7.5 was used as
the cutoff between groups. Independent predictive factors
for high levels of serum lactate in the patients with septiclity in patients with low lactate level and septic shock, Journal of
1016/j.jmii.2017.08.009
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Figure 1. Flowchart of patient selection and clinical outcome.
Table 1 Baseline data of study participants.
Characteristic High lactate (n Z 653) Low lactate (n Z 369) p-value
Age, years 66.9  13.4 63.6  15.8 0.010a
Male, (%) 366 (56.0) 157 (42.5) <0.001b
Underlying disease, yes (%)
Malignancy 238 (36.4) 111 (30.1) 0.040b
Transplantation 8 (1.2) 6 (1.6) 0.780b
Chronic heart failure 44 (6.7) 31 (8.4) 0.602b
Cardiovascular attack 101 (15.5) 61 (16.5) 0.657b
Hypertension 355 (54.4) 175 (47.6) 0.049b
Dementia 34 (5.2) 15 (4.1) 0.449b
HIV infection 0 (0.0) 1 (0.3) 0.361b
Chronic kidney disease 98 (15.0) 55 (14.9) 0.533b
Chronic liver disease 61 (9.3) 25 (6.8) 0.162b
Chronic lung disease 82 (12.6) 57 (15.5) 0.216b
Autoimmune disease 24 (3.7) 19 (5.1) 0.330b
DM 240 (36.8) 100 (27.1) 0.002b
SOFA score 9.08  3.03 6.97  2.32 <0.001a
APACHEⅡ score 18.56  7.15 14.02  5.97 <0.001a
MAP initial, mmHg 66.4  16.0 65.5  12.9 0.369a
CVP initial, cmH2O 9.6 5.3 9.6  5.0 0.919a
ScvO2 initial, % 80.2 (72.0e88.3) 83.8 (76.0e94.5) <0.001
c
Laboratory test
Lactate, mmol/L 5.55  3.27 1.27  0.44 <0.001a
Platelet, 103 cells/mm3 159.0 (87.5e247.5) 214.0 (156.3e290.0) <0.001c
CRP, mg/L 130.0 (59.2e234.0) 119.0 (59.8e198.3) 0.152c
D-dimer, ng/mL 2589 (1013e6566) 756 (470e1631) <0.001c
BUN, mg/dL 28.7 (19.2e44.4) 23.0 (15.6e36.1) <0.001c
eGFR (mL min1$1.73 m2) 39.0 (22.2e60.7) 53.0 (32.2e75.0) <0.001c
Albumin, g/dL 3.0  0.7 3.3  0.7 <0.001a
a Student’s t-test.
b Pearson’s c-test.
c ManneWhitney U-test, median (interquartile range).
ED, emergency department; CAOD, coronary artery occlusive disease; HIV, human immunodeficiency virus; DM, diabetes
mellitus; SOFA, sepsis-related organ failure assessment; APACHEⅡ, acute physiology and chronic health evaluation Ⅱ;
MAP, mean arterial pressure; CVP, central venous pressure; ScvO2, central venous O2 saturation; CRP, C-reactive protein;
BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate.
The data were expressed as number (percentage), mean  SD or number (%) or median (interquartile range).
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MAP 6h, mmHg 81.3  14.1 84.4  14.6 0.028a
CVP 6h, cmH2O 9.5  4.5 8.9  4.6 0.217a
ScvO2 6h, % 79.6 (71.8e84.8) 79.2
(74.1e85.3)
0.664c
ScvO2 goal, success 585 (89.6) 340 (92.1) 0.221
b
CP goal, success 332 (50.8) 162 (43.9) 0.037b
Organ failure
Renal 285 (43.6) 94 (25.5) <0.001b
Liver 107 (16.4) 13 (3.5) <0.001b
Heart 37 (5.7) 10 (2.7) 0.019b
ARDS 24 (3.7) 5 (1.4) 0.032b
DIC 85 (13.0) 11 (3.0) <0.001b
Use of vasopressor 621 (95.1) 358 (97.1) 0.314b
Hemodialysis 115 (17.5) 23 (6.3) <0.001b
Ventilator care 179 (27.4) 35 (9.5) <0.001b
Use of Steroid 309 (47.3) 122 (33.0) <0.001b
7-day mortality 67 (10.3) 6 (1.6) <0.001b
28-day mortality 102 (15.6) 18 (4.9) <0.001b
Hospital stay (days) 13 (7e25) 10 (7e18) 0.020c
a Student’s t-test.
b Pearson’s c-test.
c ManneWhitney U-test, median (interquartile range).
MAP, mean arterial pressure; CVP, central venous pressure;
ScvO2, central venous O2 saturation; CP, critical pathway; ARDS,
acute respiratory distress syndrome; DIC, disseminated intra-
vascular coagulation.
The data were expressed as number (percentage), mean SD or
number (%) or median (interquartile range).
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pendent (Table 3). The SOFA score was a significant variable
for predicting arterial lactate, and it showed a marked
positive correlation with serum lactate in simple correla-
tion analysis (r Z 0.394, p < 0.001) and linear regression
(R2 Z 0.155, p < 0.001; Fig. 2b).
Subgroup analysis of predictive factors for 28-day mor-
tality in the low lactate group was performed. Nine factors
were significantly associated with 28-day mortality in uni-
variate analysis: low MAP (p Z 0.009), low initial ScvO2
(p Z 0.037), low eGFR (p Z 0.028), low serum albumin
(p Z 0.013), high CRP (p Z 0.012), high arterial lactate
(p Z 0.037), high SOFA score (p < 0.001), high APACHEⅡ
score (p < 0.001), and CHF (p Z 0.005). On multivariate
analysis, high APACHEⅡ score (OR, 1.141; 95% CI,
1.047e1.243, p Z 0.003), high CRP (OR, 1.006; 95% CI,
1.000e1.011, p Z 0.034) and CHF (OR, 10.244; 95% CI,
2.763e37.980, p Z 0.001) were significant independent
predictive factors for 28-day mortality in patients with low
lactate levels (Table 4).
Discussion
Sepsis is a clinical syndrome of pathophysiologic and
biochemical abnormalities induced by infection. The
increasing incidence and high mortality rate associated
with sepsis is a major public health concern worldwide.18Please cite this article in press as: Oh DH, et al., Risk factors for morta
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tion and suggests that lactate is an important marker of
tissue damage even without hypotension.4
As an index for monitoring treatment and predicting
prognosis, several variables were proposed such as MAP,
lactate level, ScvO2, and CRP. Serum lactate levels and
ScvO2 were found to be good prognostic factors in several
studies.19,20 Mikkelsen et al. reported that initial lactate
was independently associated with mortality in patients
with severe sepsis.21 Thus, lactate is an important factor in
predicting the severity and outcome of septic shock pa-
tients, but controversy remains regarding the optimal cut-
off value. The universally accepted lactate level
representing tissue hypoxia is 4 mmol/L and is often
applied when initiating resuscitation in patients with septic
shock.12 However, Bakker and colleagues reported lactate
>2 mmol/L to be an independent predictor of mortality in
septic shock.22 In 2015, Casserly et al. reported that pa-
tients with lactate >2 mmol/L had significantly higher
mortality (42.3% [95% CI, 41.2e43.3]) in risk-adjusted
comparisons with other subgroups.6,23
Patients in the high lactate group had more severe
clinical characteristics and poorer outcomes than those in
the low lactate group. Patients in the high lactate group
also had higher SOFA score and APACHEⅡ score, and their
organ failure was more frequent than those in the low
lactate group. In addition, 7-day and 28-day mortality rates
were higher in the high lactate group than in the low
lactate group. A number of recent studies have shown that
high lactate levels are associated with poor clinical out-
comes.21,24 However, a secondary analysis study comparing
the prognosis of patients who met the new definition of
septic shock to patients who do not meet the new diag-
nostic criteria, but met the previous diagnostic criteria,
was recently published. In this study, low lactate level was
the main reason why patients did not meet the new diag-
nostic criteria. Although patients with high lactate level
fulfilled the new diagnostic criteria and had significantly
high mortality, patients with lower lactate level also had a
mortality rate of 14.4%. This mortality rate was significantly
higher than the rates of severe illness, such as stroke and
heart diseases.25 Additionally, several studies were per-
formed on the high mortality rate of patients with hypo-
lactatemia. Nichol and colleagues found that hospital
mortality was significantly increased when patients had
lactate concentrations >0.75 mmol/L and surviving pa-
tients had a median blood lactate concentration of
1.2 mmol/L, while non-survivors had a median lactate
concentration of 1.3 mmol/L (p < 0.001).10 Wacharasint
et al. reported an increase in mortality with lactate levels
>1.4 mmol/L.11 Therefore, it is necessary to use other
variables to substitute for lactate and predict the prognosis
of septic shock.
Analysis of the low lactate group revealed high APACHEⅡ
score, high CRP, and CHF to be independent prognostic
factors for 28-day mortality. Many investigators have
demonstrated that the APACHEⅡ score is a prognostic factor
influencing mortality in septic shock patients.11,26 APACHEⅡ
score is a significant prognostic factor for mortality because
it is result of the calculation includes the main physiologic
factors of critically ill patients.27 CRP is a traditional and
frequently used marker of sepsis and its management.lity in patients with low lactate level and septic shock, Journal of
1016/j.jmii.2017.08.009
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Figure 2. (a) Comparison between the high lactate group and low lactate group in 28-day mortality(p < 0.001) by KaplaneMeier
method, and (b) correlation between serum lactate and SOFA score (R2 Z 0.155, p < 0.001 by linear regression).
Table 3 Multivariate analysis of predictive factors for a
high level of serum lactate in patients with septic shock.
Variables Odds ratio (95% CI) p-value
Thrombocytopeniaa 3.279 (1.374e7.824) 0.007
eGFR, (mL min1$1.73 m2) 0.982 (0.969e0.995) 0.008
High SOFA score groupb 2.830 (1.249e6.411) 0.013
a Thrombocytopenia is defined as a platelet count under
150,000/mm3.
b A SOFA score of 7.5 on the receiver operating characteristic
curve was used as the cutoff.
eGFR, estimated glomerular filtration rate; .SOFA, sepsis-
related organ failure assessment.
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useful in monitoring the success of failure of therapy.28 The
relationship between CHF and the outcomes of septic shock
remains unclear; however, decreased heart function nega-
tively affects the outcome of septic shock. Patients in
septic shock require more oxygen transport. Therefore,
decreased heart function can lead to insufficiency in
meeting increased oxygen demands despite decreased
systemic vascular resistance resulting from septic shock.29
The prognostic value of a positive response to dobutamine
challenge in septic shock has been demonstrated in several
studies.30,31 In another study, diastolic dysfunction was a
strong independent predictor of mortality of septic shock
after adjusting for other independent predictors such as
age, diabetes mellitus, hypertension, APACHEⅡ score, and
concurrent coronary heart disease.32
Since lactate cannot be measured in some medical en-
vironments, especially outside of critical care settings, and
as there were many cases that did not check a lactate at
the time of suspected infection, even if measurementPlease cite this article in press as: Oh DH, et al., Risk factors for morta
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lactate to evaluate the severity of septic shock in patients
in these situations.6,8 Participants were divided into high
and low SOFA score groups based on a cutoff value 7.5. As a
result, thrombocytopenia, low eGFR, and high SOFA score
group were significant risk factors based on our evaluation.
Thiery-Antier et al. reported thrombocytopenia within the
first 24 h of septic shock onset as a prognostic marker of 28-
day mortality in intensive care unit patients. In multivariate
Cox regression, a platelet count 100.0  103 cells/mm3
was independently associated with significantly increased
28-day mortality. Mortality increased with the severity of
thrombocytopenia.33 In our analysis, incidence of throm-
bocytopenia was significantly high in the high lactate group
and it is a one of the significant risk factor of hyper-
lactatemia, but not a prognostic marker of 28-day mortality
in the subgroup analysis of the low lactate group. Reflecting
the pathogenesis of lactic acidosis, decreased renal func-
tion can contribute the hyperlactatemia. The kidneys
contribute to lactate clearance via excretion, gluconeo-
genesis, and oxidation, even though they may not be a
major component in lactate clearance.34 SOFA score is of
diagnostic value according to the new sepsis definition, and
correlates with lactate.4,19 In our analysis, SOFA score
showed a positive correlation with lactate, and was similar
to former studies. SOFA score may play an important role in
institutions that cannot measure lactate for management
of septic shock. A SOFA score of 8 can be a reference point
upon consideration of our analysis.
In this study, 28-day mortality was relatively lower than
the mortality rates reported in other recent studies.20,26 In
this study, 28-day mortality was 11.7% in all patients.
However, total mortality rate in this study was 16.0%. After
dividing total mortality by range of lactate, we found that
total mortality was 25.6% (103/403) in the patient grouplity in patients with low lactate level and septic shock, Journal of
1016/j.jmii.2017.08.009
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Table 4 Multivariate analysis of predictive factors for 28-day mortality in patients with low levels of serum lactate.
Variables Unadjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value
MAP, mmHga 0.939 (0.896e0.985) 0.009
ScvO2 initial 0.964 (0.932e0.998) 0.037
eGFR, (mL min1$1.73 m2) 0.980 (0.962e0.998) 0.028
Albumin, mg/dL 0.431 (0.222e0.835) 0.013
CRP, mg/L 1.006 (1.001e1.010) 0.012 1.006 (1.000e1.011) 0.034
Lactate, mmol/L 3.366 (1.073e10.555) 0.037
SOFA score 1.446 (1.198e1.745) <0.001
APACHEⅡ score 1.156 (1.074e1.243) <0.001 1.141 (1.047e1.243) 0.003
Chronic heart failure 4.808 (1.591e14.531) 0.005 10.244 (2.763e37.980) 0.001
a At the time of admission to the emergency department.
MAP, mean arterial pressure; ScvO2, central venous O2 saturation; eGFR, estimated glomerular filtration rate; CRP, C-reactive protein;
APACHEⅡ, acute physiology and chronic health evaluation Ⅱ; OR, odds ratio; CI, confidence interval.
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+ MODELwith lactate >4 mmol/L, which was significantly higher
than mortality of the patient group with lactate <1 mmol/L
(5.8%, 8/138, p < 0.001). Additionally, the relatively high
number of patients with urinary tract infection who were
known to have a good prognosis could be a reason (nZ 294,
28.8%). In other words, these results indicate that lactate is
a reliable prognostic marker in septic shock patients.
This study had several limitations. First, the clinical and
biological data used in this study were collected from a
single center. Second, nosocomial infections were excluded
due to the collection of data from ED admissions. For the
same reason, there is a possibility for selection bias. Since
the initiation of CP was mainly dependent on the decision
of physicians at the ED, their subjective judgment may have
interfered with CP enrollment. Third, patients who needed
emergency surgery with a high likelihood of septic shock
were excluded from the study. Patients who needed
emergency surgery were excluded in CP protocol design
since the initial 6-h management bundle was difficult to
apply in the same environment as other patients. However,
it is not necessary to maintain the existing 6-h bundle when
managing patients with septic shock according to the
recently revised SSC guideline.35 Therefore, it may be
possible to enroll patients who require emergency surgery
in CP in future protocol revision and research design.
Finally, since this was a long-term period study, changes in
medical devices, techniques, and antibiotics over time
were not entirely reflected. However, this study has been
carefully conducted and includes a significant number of
participants while considering strict definition of septic
shock. In addition, we found that the predictive power for
key variables was sufficiently high in the final multivariate
logistic regression model.
Our study demonstrates that arterial lactate level is a
very reliable diagnostic and prognostic predictor of septic
shock. SOFA score correlated well with arterial lactate.
However, there were not inconsiderable cases of mortality
in patients without hyperlactatemia. In the low lactate
group, high APACHEⅡ score, high CRP, and CHF affected the
mortality rate independently. Re-examination of arterial
lactate should be considered when treating patients with
suspected septic shock and low arterial lactate, if the pa-
tient has high APACHEⅡ score, high CRP, and CHF. Further
studies are needed that will identify other predictivePlease cite this article in press as: Oh DH, et al., Risk factors for morta
Microbiology, Immunology and Infection (2017), http://dx.doi.org/10.
Downloaded for Anonymous User (n/a) at KESLI - Yonsei University M
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hyperlactatemia.
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